Concourse Financial Group Securities, Inc. Ascendis Pharma A/S Transaction History

Concourse Financial Group Securities, Inc.

$1.56 Billion
Q2 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 23, 2024	BUY	$121.07 - $153.67 $0 - $0	0 New	0 $0
Q1 2024 Apr 30, 2024	BUY	$123.45 - $159.4 $0 - $0	0 New	0 $0
Q4 2023 Feb 07, 2024	BUY	$86.1 - $127.36 $0 - $0	0 New	0 $0
Q3 2023 Oct 30, 2023	BUY	$86.5 - $103.97 $0 - $0	0 New	0 $0
Q3 2023 Oct 25, 2023	BUY	$86.5 - $103.97 $0 - $0	0 New	0 $0
Q2 2023 Aug 10, 2023	BUY	$69.96 - $97.84 $0 - $0	0 New	0 $0
Q1 2023 May 15, 2023	BUY	$104.9 - $126.78 $0 - $0	0 New	0 $0
Q4 2022 Jan 30, 2023	BUY	$99.42 - $131.97 $0 - $0	0 New	0 $0
Q3 2022 Nov 15, 2022	BUY	$84.03 - $110.23 $0 - $0	0 New	0 $0
Q2 2022 Aug 09, 2022	BUY	$78.08 - $117.61 $0 - $0	0 New	0 $0
Q1 2022 May 09, 2022	SELL	$102.18 - $135.75 $715 - $950	-7 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$127.1 - $169.66 $46,264 - $61,756	-364 Reduced 98.11%	7 $1,000
Q3 2021 Nov 09, 2021	SELL	$112.67 - $176.92 $6,534 - $10,261	-58 Reduced 13.52%	371 $59,000
Q2 2021 Aug 13, 2021	BUY	$121.62 - $145.29 $1,459 - $1,743	12 Added 2.88%	429 $56,000
Q1 2021 May 13, 2021	BUY	$124.92 - $173.33 $8,994 - $12,479	72 Added 20.87%	417 $54,000
Q4 2020 Feb 02, 2021	BUY	$151.2 - $182.76 $9,828 - $11,879	65 Added 23.21%	345 $58,000
Q3 2020 Nov 13, 2020	BUY	$134.29 - $154.32 $15,174 - $17,438	113 Added 67.66%	280 $43,000
Q2 2020 Aug 13, 2020	BUY	$110.87 - $156.01 $18,515 - $26,053	167 New	167 $25,000
Q1 2020 May 13, 2020	BUY	$97.01 - $145.11 $0 - $0	0 New	0 $0
Q4 2019 Feb 14, 2020	BUY	$91.45 - $139.12 $0 - $0	0 New	0 $0
Q3 2019 Nov 13, 2019	BUY	$95.8 - $118.9 $0 - $0	0 New	0 $0
Q2 2019 Aug 13, 2019	BUY	$107.11 - $132.09 $0 - $0	0 New	0 $0
Q1 2019 May 15, 2019	BUY	$62.15 - $129.99 $0 - $0	0 New	0 $0
Q4 2018 Feb 14, 2019	BUY	$55.16 - $69.67 $0 - $0	0 New	0 $0
Q3 2018 Nov 13, 2018	BUY	$63.77 - $76.28 $0 - $0	0 New	0 $0

Others Institutions Holding ASND

# of Institutions

223

Shares Held

56.5M

Call Options Held

142K

Put Options Held

259K

Ra Capital Management, L.P. Boston, MA

10.1M
Shares

$1.55 Billion
20.78% of portfolio
Westfield Capital Management CO LP Boston, MA

4.96M
Shares

$761 Million
3.41% of portfolio
Artisan Partners Limited Partnership Milwaukee, WI

4.3M
Shares

$659 Million
0.93% of portfolio
Avoro Capital Advisors LLC New York, NY

4.2M
Shares

$644 Million
7.81% of portfolio
Janus Henderson Group PLC London, X0

3.92M
Shares

$601 Million
0.29% of portfolio

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $8.56B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account